Loretta Tse

Loretta joined Tekla Capital Management LLC in 2015, where she is responsible for all aspects of executing on and managing venture investments on behalf of the Tekla Funds.

Previously, Dr. Tse ran a biotech consulting business and worked with various venture funds and start-up companies. Prior to that, Dr. Tse was Managing Director, Technology Transfer and Industry Relations at Fred Hutchinson Cancer Research Center, where she ran an office that was responsible for protection and commercialization of research output and formation of start-up companies. She was also an Associate at Oxford Biosciences Partners, an early-stage Life Sciences venture fund, and worked in business development at several early-stage biotech companies prior to joining Oxford.

Dr. Tse holds a Ph.D. in Pharmacology from Johns Hopkins School of Medicine, where her research involved EBV gene regulation. She also studied the HIV CCR5 coreceptor as a post-doctoral fellow at the Henry M. Jackson Foundation and has a B.S. in Biochemistry from the University of California, Davis.